Core Areas of Contribution
Sepsis & Hyperinflammation
In the pivotal 2022 paper “Chasing the Ghost: Hyperinflammation
Does Not Cause Sepsis,” Dr. Shapiro and collaborators attacked
the “cytokine storm” paradigm — highlighting the unappreciated
facts that decades of anti-inflammatory trials failed, cytokine levels in
sepsis are insufficient to cause damage, and the paradigm persists despite
contradictory evidence (ResearchGate, Frontiers). Their work calls for
abandoning this inadequate theory and redirecting efforts toward a more
coherent framework of sepsis pathogenesis.
COVID-19 Diagnostics & Treatment Analysis
Building on the sepsis work, Dr. Shapiro has critically examined COVID-19
treatment strategies. He co-authored studies on empiric therapies in 2020,
including questioning IL-6 blockade (Frontiers). Dr. Shapiro and colleagues
published a detailed analysis of the premature acceptance of Interleukin-1
blockade as a COVID-19 treatment. Bold predictions offered in this paper
are proving correct. Their analyses cautioned that anti-inflammatory
approaches for COVID-19 were “destined to fail”
(som.cuanschutz.edu).
Notably, in 2021, Dr. Shapiro led the development of a practical
diagnostic tool using the ferritin-to-procalcitonin (F/P) ratio to
distinguish COVID-19 pneumonia from bacterial pneumonia — showing that a
F/P threshold provided significant diagnostic accuracy (PMC). A
theoretical approach to constructing this biomarker tool represents an
approach designed to circumvent the looming reproducibility crisis
generated by the indiscriminate combination of big data and superfast
computer analyses.